Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181077 · ClinicalTrials.gov registry record · Phase 1
Hypertonic Saline Use in Preeclampsia
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00181077: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00181077 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181077, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia.
Interventions
- DRUG 2% buffered hypertonic saline administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00181077
The ClinicalTrials.gov registry entry for NCT00181077 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2% buffered hypertonic saline administration is the first listed.
NCT00181077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00181077 about?
NCT00181077 is a clinical study titled "Hypertonic Saline Use in Preeclampsia". To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia.
What is the current status of trial NCT00181077?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2003-06. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00181077?
The interventions under investigation include: 2% buffered hypertonic saline administration (DRUG).
Who is sponsoring clinical trial NCT00181077?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.